Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|7|936-944

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.7, 2015-06, pp. : 936-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Different cerebrospinal fluid levels of Alzheimer‐type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 853-858

John Wiley & Sons Inc

Access to resources Recommend Favorite

Somatostatin‐Like Immunoreactivity in the Cerebrospinal Fluid of Aged Patients with Parkinson's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 38, Iss. 1, 1990-01 ,pp. : 19-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early‐stage Parkinson's disease

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 6, 2015-12 ,pp. : 1000-1004

John Wiley & Sons Inc

Access to resources Recommend Favorite

Creutzfeldt-Jakob Disease and Homocysteine Levels in Plasma and Cerebrospinal Fluid

By  

Gerontology, Vol. 51, Iss. 2, 2005-02 ,pp. : 142-144

Karger

Access to resources Recommend Favorite

ELEVATED CEREBROSPINAL FLUID TAU LEVELS: IMPLICATIONS FOR THE EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 8, 1996-08 ,pp. : 1012-1013

John Wiley & Sons Inc

Access to resources Recommend Favorite